Experimental Nuclear Medicine Meets Tumor Biology

Experimental Nuclear Medicine Meets Tumor Biology

Personalized treatment of cancer patients demands specific and validated biomarkers for tumor diagnosis and therapy. The development and validation of such require translational preclinical models that recapitulate human diseases as accurately as possible. Moreover, there is a need for convergence o...

Full description

Bibliographic Details
Main Authors: Theresa Balber, Loan Tran, Katarína Benčurová, Julia Raitanen, Gerda Egger, Markus Mitterhauser
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Pharmaceuticals
Subjects:
molecular imaging
molecular pathology
cancer biomarkers
biomarker imaging
tracer development
in vitro models
Online Access:https://www.mdpi.com/1424-8247/15/2/227

Internet

https://www.mdpi.com/1424-8247/15/2/227

Similar Items